![Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire](https://mms.businesswire.com/media/20191104005226/en/753988/23/4096453_3004008_Can-Fite_logo.jpg)
Can-Fite Initiates Compassionate Use Program for Namodenoson in the Treatment of Liver Cancer, Enrolls and Treats Patients | Business Wire
![Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson | Business Wire Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson | Business Wire](https://mms.businesswire.com/media/20200316005169/en/633723/23/Can-Fite_logo_no_shadow_%5B1%5D.jpg)
Can-Fite: Progress in Compassionate Use Program Treating Advanced Liver Cancer Patients with Namodenoson | Business Wire
UT Southwestern Radiation Oncology - Congratulations to Dr. Prasanna Alluri, Assistant Professor of Radiation Oncology at UT Southwestern, and Dr. Salomon Stemmer, Professor in Oncology at Rabin Medical Center, for being awarded
![Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry | npj Breast Cancer Clinical outcomes in patients with node-negative breast cancer treated based on the recurrence score results: evidence from a large prospectively designed registry | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-017-0034-6/MediaObjects/41523_2017_34_Fig1_HTML.jpg)